menu
menu
Stay informed of the latest news and alerts critical to the industry, and the role you can play alongside ASCP to advocate for the best interest of both professionals and patients.
Featured Article
ASCP and four medical specialty societies are bolstering a lawsuit to fight the FDA's claim to regulatory authority over LDTs.
ASCP serves as an unrelenting advocate for pathologists, laboratory professionals, and patients alike, driving positive, impactful change that serves the best interest of our members as well as patient care.
Publications
ASCP is encouraging everyone, whether they are an ASCP member or not, to stand up for the laboratory profession by urging their members of Congress to fix the Medicare Physician and Clinical Laboratory Fee Schedules.
Read ArticleNovember 12, 2024
November 08, 2024
Inside the Lab
Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory?The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This podcast is designed to help pathologists and laboratory professionals gain an understanding of plasma testing for markers such as Abeta40/42, P-tau181, and P-tau217 which are rapidly appearing in the commercial space and how healthcare providers have begun incorporating these tests into routine neurology practice. This podcast will help participants to understand the advantages and limitations of these assays as well as their potential application when a physician is evaluating a patient for AD.
